Indivumed Therapeutics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 89

Employees

  • Latest Deal Type
  • Debt

  • Latest Deal Amount
  • $4.88M

Indivumed Therapeutics General Information

Description

Provider of target discovery services intended to advance precision oncology therapeutics. The company offers validated therapeutic targets, lead compound development, diagnostic signatures, biomarker discovery, clinical trial performance, and target out-licensing, enabling biotechnology companies to identify novel therapeutic targets grounded in native human tumor biology.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • Falkenried 88
  • Building D
  • 20251 Hamburg
  • Germany
+49 040
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Vertical(s)
Corporate Office
  • Falkenried 88
  • Building D
  • 20251 Hamburg
  • Germany
+49 040

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Indivumed Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Debt - General 17-Jan-2022 $4.88M Completed Generating Revenue
1. Debt - General 08-Jan-2018 Completed Generating Revenue
To view Indivumed Therapeutics’s complete valuation and funding history, request access »

Indivumed Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of target discovery services intended to advance precision oncology therapeutics. The company offers validated
Drug Discovery
Hamburg, Germany
89 As of 2026

Newton, MA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Indivumed Therapeutics Competitors (65)

One of Indivumed Therapeutics’s 65 competitors is Auron Therapeutics, a Venture Capital-Backed company based in Newton, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Auron Therapeutics Venture Capital-Backed Newton, MA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
Parion Sciences Venture Capital-Backed Durham, NC
WaVe Life Sciences Formerly VC-backed Cambridge, MA
Tenax Therapeutics Formerly VC-backed Chapel Hill, NC
You’re viewing 5 of 65 competitors. Get the full list »

Indivumed Therapeutics Patents

Indivumed Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260226557-A1 Cancer subtype identifier and method for classifying tumors Pending 20-Dec-2024
WO-2026132084-A2 Cancer subtype identifier and method for classifying tumors Pending 20-Dec-2024
WO-2026132084-A3 Cancer subtype identifier and method for classifying tumors Pending 20-Dec-2024
EP-4698681-A1 Colorectal cancer subtype identifier Pending 20-Apr-2023
JP-2026514729-A Colorectal cancer subtype identifier Pending 20-Apr-2023 C12Q1/6886
To view Indivumed Therapeutics’s complete patent history, request access »

Indivumed Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Indivumed Therapeutics Investments (2)

Indivumed Therapeutics’s most recent deal was a Joint Venture with Ix Therapeutics. The deal was made on 18-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ix Therapeutics 18-Mar-2021 Joint Venture Drug Discovery
Sysmex Inostics Early Stage VC Laboratory Services (Healthcare)
To view Indivumed Therapeutics’s complete investments history, request access »

Indivumed Therapeutics Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Ix Therapeutics Hamburg, Germany 2021
Indivutest Hamburg, Germany 2011

Indivumed Therapeutics FAQs

  • When was Indivumed Therapeutics founded?

    Indivumed Therapeutics was founded in 2001.

  • Where is Indivumed Therapeutics headquartered?

    Indivumed Therapeutics is headquartered in Hamburg, Germany.

  • What is the size of Indivumed Therapeutics?

    Indivumed Therapeutics has 89 total employees.

  • What industry is Indivumed Therapeutics in?

    Indivumed Therapeutics’s primary industry is Drug Discovery.

  • Is Indivumed Therapeutics a private or public company?

    Indivumed Therapeutics is a Private company.

  • What is Indivumed Therapeutics’s current revenue?

    The current revenue for Indivumed Therapeutics is .

  • How much funding has Indivumed Therapeutics raised over time?

    Indivumed Therapeutics has raised $52.5M.

  • Who are Indivumed Therapeutics’s competitors?

    Auron Therapeutics, Sorrento Therapeutics, Parion Sciences, WaVe Life Sciences, and Tenax Therapeutics are some of the 65 competitors of Indivumed Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process